ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryWinterthurTrias Pharma GmbH
Trias Pharma GmbH Logo
Verified· 2 sources

Trias Pharma GmbH

Summary

About the company

The core activity of Trias Pharma GmbH is the development and manufacture of solid dosage forms, in particular oral dosage forms such as tablets and soft capsules, as well as the provision of analytical support services and expertise in the field of drug development, including the development of medical cannabis.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered
8
CMC consulting for formulation and analytical development
CMC consulting for formulation, analytical development and documentation of solid dosage forms up to submission; including patent landscape, regulatory assessment, on-site support and third-party management.
Sourcing and management of CMOs
Identification and evaluation of CMOs, benchmarking, RFQ management, coordination of the involved parties, as well as project structure and reporting for development and manufacturing projects.
CMC writing
Preparation of development reports and CTD modules for IND/IMPD files as well as for registration dossiers; based on formulation and analytical development experience.
Troubleshooting for dosage forms
Analysis and problem solving for softgel capsules and solid dosage forms based on document review as well as analytical and manufacturing-technical aspects.
Development of tablets and hard capsules
Formulation concepts, process know-how and development of immediate-release and modified-release forms up to MUPS; including direct compression, wet and dry agglomeration and film coating.
Softgel capsule development
Development of softgel capsules from concept to final product; know-how regarding excipients, formulations, process development and regulatory aspects, as well as documentation and risk assessment.
Development of medical cannabis
Pharmaceutical support for medical cannabis, transition to standardized cannabis medicines, as well as development of oral and pulmonary dosage forms and inhalation devices.
Analytical development
Analytical development for complex dosage forms, in particular softgel capsules and modified-release tablets; method selection, solution development, validation and partner laboratory networking.
Comparisons

Trias Pharma GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Trias Pharma GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Trias Pharma GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Technoparkstrasse 2
8406 Winterthur

At a glance

Legal form
Limited Liability Company
UID
CHE-419.005.645
Founded
2016 · 10 years
Last commercial register change
January 28, 2026
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Trias Pharma GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

MA
Medropharm AG
Zurich
SP
swisscann pharma GmbH
Zurich
ST
swisscann tec AG
Zurich
IS
IMCD Switzerland AG
Zurich
SP
steinberg pharma ag
Winterthur
AH
AeoniQ Holding AG
Schlieren
PG
PharConSwiss GmbH
Winkel
BC
Biotech Concepts GmbH
Zurich